Skip to main content
    C

    Coya Therapeutics, Inc. Common Stock (COYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    -0.13 (-4.15%)

    Market Cap: $73.42M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Coya Therapeutics, Inc. Common Stock (COYA) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Coya Therapeutics, Inc. Common Stock (COYA) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Coya Therapeutics, Inc. Common Stock reported EPS of -$0.45, below the -$0.35 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    60%(9/15)
    Avg Surprise
    -8.04%

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.40
    Range-$0.49 - -$0.33
    9 analysts
    Revenue Consensus
    $512.92K
    RangeN/A
    9 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.48
    Range-$0.52 - -$0.44
    3 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.45-6.6%
    60d ago-$0.46-5.8%
    30d ago-$0.46-5.8%
    7d ago-$0.480.0%
    Current-$0.48
    Revenue Consensus
    $100.00K
    RangeN/A
    3 analysts

    Next Report

    COYA has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 15 quarters below that had an estimate, COYA beat 9 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $234134, down 93.4% from $3.56M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.45-$0.35-$0.37 - -$0.33-28.57%MissN/A32 up, 0 downNov 10, 2026$234134
    Jun 30, 2026-$0.28-$0.36-$0.37 - -$0.36+22.22%BeatN/A41 up, 1 downAug 11, 2026$243745
    Mar 31, 2026-$0.32-$0.69N/A+53.87%BeatN/A30 up, 2 downMay 12, 2026$251147
    Dec 31, 2025-$0.34-$0.30-$0.43 - -$0.08-13.33%MissN/A42 up, 0 downMar 16, 2026$3.96M
    Sep 30, 2025-$0.13-$0.30-$0.43 - $0.02+56.67%BeatN/A41 up, 0 downNov 12, 2025$3.56M
    Jun 30, 2025-$0.36-$0.43-$0.47 - -$0.40+16.28%BeatN/A31 up, 1 downAug 12, 2025$163616
    Mar 31, 2025-$0.44-$0.12-$0.22 - -$0.03-266.67%MissN/A20 up, 0 downMay 13, 2025$257884
    Dec 31, 2024-$0.18-$0.40N/A+55.00%Beat-220.0%10 up, 0 downMar 18, 2025$1952
    Sep 30, 2024-$0.26-$0.41-$0.47 - -$0.31+36.59%BeatN/A40 up, 0 downNov 6, 2024N/A
    Jun 30, 2024-$0.19-$0.14-$0.14 - -$0.14-35.71%MissN/A10 up, 0 downAug 12, 2024$3.43M
    Mar 31, 2024-$0.35-$0.29N/A-20.69%MissN/A10 up, 0 downMay 9, 2024$126838
    Dec 31, 2023$0.15$0.26$0.26 - $0.26-42.31%MissN/A10 up, 0 downMar 19, 2024$6.00M
    Sep 30, 2023-$0.34-$0.37-$0.37 - -$0.37+8.11%BeatN/A10 up, 0 downNov 8, 2023N/A
    Jun 30, 2023-$0.31-$0.32-$0.33 - -$0.31+3.13%BeatN/A20 up, 0 downAug 8, 2023N/A
    Mar 31, 2023-$0.28-$0.43-$0.43 - -$0.43+34.88%BeatN/A10 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$0.31N/AN/AN/AN/AN/AN/AN/AMar 29, 2023N/A
    Sep 30, 2022-$0.20N/AN/AN/AN/AN/AN/AN/ADec 30, 2022N/A
    Last 17 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.27, after -$0.98 the year before. It was -$0.51 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.27N/A
    Dec 31, 2024-$0.98N/A
    Dec 31, 2023-$0.78N/A
    Dec 31, 2022-$0.51N/A

    Frequently Asked Questions About COYA

    When is Coya Therapeutics, Inc. Common Stock's next earnings date?

    Coya Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 15, 2027.

    Did COYA beat earnings estimates last quarter?

    No. Coya Therapeutics, Inc. Common Stock reported EPS of -$0.45 for the quarter ended Sep 30, 2026, below the -$0.35 estimate by 28.57%.

    What EPS do analysts expect from COYA next quarter?

    The consensus EPS estimate for Coya Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.40 from 9 analysts, with estimates from -$0.49 to -$0.33.

    How often does COYA beat earnings estimates?

    Coya Therapeutics, Inc. Common Stock beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -13.07%.